Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

News releases from AC Immune SA

< Previous 1 2 3 Next >
AC Immune to Present New Data from Alpha-Synuclein and TDP-43 Programs at the AD/PD™ 2021 Virtual Conference
Tickers ACIU
From GlobeNewswire News Releases
AC Immune to Highlight Promising Alzheimer’s Vaccine at the SVB Leerink 10th Annual Global Healthcare Conference
Tickers ACIU
From GlobeNewswire News Releases
AC Immune’s Alzheimer’s Vaccine Generates Potent Anti-pTau Antibody Response in a Phase 1b/2a Study
Tickers ACIU
From GlobeNewswire News Releases
AC Immune Initiates Clinical Study of First-in-class Diagnostic for Parkinson’s Disease
Tickers ACIU
From GlobeNewswire News Releases
AC Immune Reports Progress for Therapeutic Programs Targeting the NLRP3 Inflammasome Pathway
Tickers ACIU
From GlobeNewswire News Releases
AC Immune Receives Competitive Target ALS Foundation Grant to Accelerate the Development of Proprietary Phosphorylated TDP-43 Immuno-assay
Tickers ACIU
From GlobeNewswire News Releases
Immunotherapy Pioneer Prof. Carl H. June Joins AC Immune’s Board of Directors
Tickers ACIU
From GlobeNewswire News Releases
Neurologist and Psychiatrist Prof. Johannes Rolf Streffer, MD Joins AC Immune SA as Chief Medical Officer
Tickers ACIU
From GlobeNewswire News Releases
AC Immune Reports Q3 2020 Financial Results and Provides Business Update
Tickers ACIU
From GlobeNewswire News Releases
AC Immune to Provide Strategy and Pipeline Update During Jefferies Virtual London Healthcare Conference
To feature discussion of the Company’s world-leading therapeutic and diagnostic candidates targeting TDP-43 
Tickers ACIU
From GlobeNewswire News Releases
AC Immune and WuXi Biologics Strengthen Strategic Partnership to Accelerate AC Immune’s Anti-TDP-43 Antibodies into Clinical Development
Strategic partnership reflects AC Immune’s growing expertise in monoclonal antibody development 
Tickers ACIU
From GlobeNewswire News Releases
Competitive EU Grant Supports Collaboration to Accelerate Development of AC Immune's First-in-Class TDP-43 Diagnostic Agent
Tickers ACIU
From GlobeNewswire News Releases
AC Immune Reports Top Line Results from TAURIEL Phase 2 Trial Evaluating Semorinemab in Early Alzheimer’s Disease
Tickers ACIU
From GlobeNewswire News Releases
AC Immune to Showcase Anti-Tau Portfolio at H.C. Wainwright 22nd Annual Global Investment Conference
Tickers ACIU
From GlobeNewswire News Releases
AC Immune Reports Q2 2020 Financial Results and Provides Business Update
Tickers ACIU
From GlobeNewswire News Releases
AC Immune Initiates IND-Enabling Studies for First-in-Class Antibody Targeting TDP-43 to Treat Neurodegeneration
Tickers ACIU
From GlobeNewswire News Releases
AC Immune Wins Prestigious Award to Develop a “Game-Changing” Parkinson’s Diagnostic Tool
Tickers ACIU
From GlobeNewswire News Releases
AC Immune Demonstrates Enhanced Performance of First-in-class Parkinson’s Diagnostic Agent
Tickers ACIU
From GlobeNewswire News Releases
AC Immune to Present Advances in Two of the Company’s World Leading Programs at the Upcoming Alzheimer’s Association International Conference
Presentations to highlight the Company’s broad expertise addressing both novel and well-established targets in neurodegenerative diseases 
Tickers ACIU
From GlobeNewswire News Releases
AC Immune Advances phospho-Tau Alzheimer’s Vaccine in Phase 1b/2a Study
Tickers ACIU
From GlobeNewswire News Releases
Tau-PET Tracer PI-2620 Could Set New Standards for an Improved Diagnosis of Progressive Supranuclear Palsy
Results published in JAMA Neurology demonstrate the potential for a best-in-class diagnostic tool 
Tickers ACIU
From GlobeNewswire News Releases
AC Immune Announces Results of Annual General Meeting
Tickers ACIU
From GlobeNewswire News Releases
AC Immune CEO to Showcase Novel Target Programs at UBS Global Healthcare Conference
Tickers ACIU
From GlobeNewswire News Releases
AC Immune Reports Q1 2020 Financial Results and Provides Business Update
Tickers ACIU
From GlobeNewswire News Releases
AC Immune Presents the Latest Preclinical Data on Novel Drug Targets for Neurodegenerative Diseases
Tickers ACIU
From GlobeNewswire News Releases
AC Immune Reports Full-Year 2019 Financial Results and Provides 2020 R&D Outlook
Tickers ACIU
From GlobeNewswire News Releases
AC Immune Receives Second Milestone and New Milestone to Increase the Potential Deal Value of Lilly Morphomer™ Tau Partnership
Tickers ACIU
From GlobeNewswire News Releases
Internationally Renowned Neurologist Dr. Juan Fortea Joins AC Immune’s Clinical Advisory Board
Latest appointment further reinforces the depth and breadth of the Company’s clinical development competences in Down syndrome-related Alzheimer’s disease 
Tickers ACIU
From GlobeNewswire News Releases
AC Immune to Present New Data Demonstrating the Depth of its Neurodegenerative Programs at the Upcoming Advances in Alzheimer’s and Parkinson’s Therapies Focus Meeting
Four presentations at AAT-AD/PD™ focus meeting 
Tickers ACIU
From GlobeNewswire News Releases
AC Immune to Present at Jefferies 2019 London Healthcare Conference
Tickers ACIU
From GlobeNewswire News Releases
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.